Segmed Secures $10.4 Million Series A Funding, Led by iGan Partners and Advocate Health

Palo Alto, Calif., September 3rd, 2024—Segmed, Inc., a leader in providing real-world imaging data for health innovation, has raised a $10.4 million Series A funding round. The oversubscribed round was led by iGan Partners and Advocate Health, with participation from Castellan Group, Engine Health Capital, Bold Brain Ventures, Fox Chase Cancer Center, and current investors including Y Combinator, Nina Capital, Nova Capital, Blumberg Capital, and Expeditions Fund. The current Series A round follows a financing by Flashpoint Growth Debt Fund received in 2023.

Read More